Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endotoxin tolerance fingerprint study
NL-OMON48466Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- May 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial of lipopolysaccharide endotoxin, sponsored by Radboud University Medical Center. Primary endpoints: Genetic and transcriptomic predictors of endotoxin tolerance and Extent of endotoxin tolerance. Started May 2019; status: active, not recruiting.
02
Drugs
lipopolysaccharide endotoxin
Beyond the preview
Go deeper on NL-OMON48466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48466.